Results 101 to 110 of about 44,321 (240)

Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies

open access: yesJournal of Applied Entomology, Volume 150, Issue 7, Page 990-1015, August 2026.
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi   +4 more
wiley   +1 more source

A real-world based study for immunogenicity and safety for three immunization schedules of polio vaccine

open access: yesScientific Reports
To evaluate the immunogencity and safety for three immunization schedules of inactivated poliovirus vaccine (IPV) and bivalent oral poliovirus vaccine (bOPV) for providing a basis for further optimization of the polio sequential immunization schedule. To
Li Sun   +11 more
doaj   +1 more source

The Synthetic Melanocortin Agonist NDP‐MSH Ameliorates THSD7A‐Associated Membranous Nephropathy in an Active Immunization Mouse Model

open access: yesThe FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Active immunization with recombinant THSD7A in mice induces autoreactive B cell activation and differentiation into CD138+ antibody‐secreting cells, leading to the production of anti‐THSD7A autoantibodies, glomerular immune injury and proteinuria, characteristic of membranous nephropathy. NDP‐MSH treatment modulates the MITF/IRF4 axis in primed B cells,
Mingzhuo Zhang   +4 more
wiley   +1 more source

Influenza prevention and treatment by passive immunization. [PDF]

open access: yes, 2014
Passive immunity is defined as a particular antigen resistance provided by external antibodies. It can be either naturally or artificially acquired. Natural passive immunization occurs during pregnancy and breast-feeding in mammals and during hatching in
Sirko, Agnieszka   +3 more
core  

Perspectives on Pertussis Prevention

open access: yes
Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Chemo‐Immunotherapy, a Combination Approach for the Treatment of HER2‐Positive Breast Cancer in a Mouse Model

open access: yesCancer Medicine, Volume 15, Issue 7, July 2026.
Experimental workflow of HER2/Neu‐targeted dendritic cell‐based chemo‐immunotherapy in a 4T1‐HER2 breast cancer xenograft model. ABSTRACT The discovery of tumor‐associated antigens has been a significant milestone for cancer therapy as the current conventional therapies (radiotherapy, chemotherapy) were found to be insufficient in terms of cancer ...
Cenk Serhan Özverel   +4 more
wiley   +1 more source

Active and passive immunization for atherosclerosis

open access: yes, 2007
This review summarizes experimental findings that highlight the role of immune mechanisms in atherosclerosis and the potential atheroprotective effects of active or passive immunization strategies.
Chyu, Kuang-Yuh   +2 more
core  

Investigating the Role of Anti‐Leukemia Inhibitory Factor Antibody on Cytokine Profile in a Mouse Model of Breast Cancer

open access: yesCancer Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background Leukemia inhibitory factor (LIF), a member of the IL‐6 cytokine family, is increasingly recognized as a tumor‐promoting factor in breast cancer, where it contributes to immune suppression, tumor progression, and therapy resistance.
Seyed Mohammad Seifati   +3 more
wiley   +1 more source

Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV

open access: yes, 2002
Passive immunization with synergistic combinations of human monoclonal antibodies (mAbs) directed against conserved epitopes of the human immunodeficiency virus (HIV) envelope completely protected 13 out of 16 rhesus monkeys challenged intravenously or ...
Hofmann-Lehmann, Regina; https://orcid.org/   +3 more
core   +1 more source

Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization [PDF]

open access: yes, 2016
Author Summary: Vaccine and passive immunization prophylactic trials that rely on antibody-mediated protection are planned for HIV-1 clade C epidemic regions of southern Africa, which have amongst the highest HIV-1 incidences globally.
Lynn Morris (7883)   +173 more
core   +1 more source

Home - About - Disclaimer - Privacy